Phase 3b, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Trial of Linaclotide Administered Orally for 12 Weeks to Patients With Chronic Constipation and Prominent Abdominal Bloating at Baseline.
Phase of Trial: Phase III
Latest Information Update: 28 Apr 2016
At a glance
- Drugs Linaclotide (Primary)
- Indications Constipation
- Focus Therapeutic Use
- Sponsors Forest Laboratories
- 19 Oct 2015 Results presented at the American College of Gastroenterology 2015 Scientific Meeting, as per Ironwood Pharmaceuticals media release.
- 01 Aug 2013 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 25 Jul 2013 Data is expected from this trial in Q3 2013, according to an Ironwood media release.